An age-structured model for pertussis transmission

Mathematical Biosciences

Volumn 145, Issue 2, 1997, Pages 89-136

  Hethcote, Herbert W ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVE IMMUNIZATION; ARTICLE; COMPUTER SIMULATION; DATA ANALYSIS; DISEASE TRANSMISSION; MATHEMATICAL MODEL; PERTUSSIS; PREVALENCE; UNITED STATES;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COMPUTER SIMULATION; HISTORY, 20TH CENTURY; HUMANS; INFANT; INFANT, NEWBORN; MATHEMATICS; MIDDLE AGED; MODELS, BIOLOGICAL; PERTUSSIS VACCINE; UNITED STATES; WHOOPING COUGH;

EID: 0030867201     PISSN: 00255564     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-5564(97)00014-X     Document Type: Article

References (78)

1. 1 J. E. Gordon and R. I. Hood, Whooping cough and its epidemiological anomalies, Am. J. Med. Sci. 222:333-361 (1951).
2. 2 A. S. Benenson, Control of Communicable Diseases Manual, 16th ed., American Public Heath Association, 1995.
3. 3 Centers for Disease Control and Prevention, Pertussis surveillance: United States, 1989-1991, Morb. Mortal. Wkly. Rep. (no. SS-8) 41:11-20 (1992).
4. 4 Centers for Disease Control and Prevention, Recommended childhood immunization schedule: United States, 1997, Morb. Mortal. Wkly. Rep. 46:35-40 (1997).
5. 5 E. A. Mortimer, Pertussis and pertussis vaccines: 15 years of change, Semin. Pediatr. Infect. Dis. 2:82-90 (1991).
6. 6 J. W. Bass and S. R. Stephenson, The return of pertussis, Pediatr. Infect. Dis. J. 6:141-144 (1987).
7. 7 C. H. W. von Konig, S. Postels-Multani, H. L. Bock, and H. J. Schmitt, Pertussis in adults: frequency of transmission after household exposure, Lancet 346:1326-1329 (1995).
8. 8 S. Schmitt-Grohe, J. D. Cherry, U. Heininger, M. A. Überall, E. Pineda and K. Stehn, Pertussis in German adults, Clin. Infect. Dis. 21:860-866 (1995).
9. 9 C. A. M. Mink, J. D. Cherry, P. Christenson, K. Lewis, E. Pineda, D. Shlian, J. A. Dawson and D. A. Blumberg, A search for Bordetella pertussis infection in university students, Clin. Infect. Dis. 14:464-471 (1992).
10. 10 J. W. Bass, Pertussis: current status of prevention and treatment, Pediatr. Infect. Dis. 4:614-619 (1985).
11. 11 J. D. Cherry, L. J. Baraff, and E. Hewlett, The past, present and future of pertussis, West. J. Med. 150:319-328 (1989).
12. 12 K. M. Farizo, S. L. Cochi, E. R. Zell, E. W. Brink, S. G. Wassilak, and P. A. Patriarca, Epidemiological features of pertussis in the United States, 1980-1989, Clin. Infect. Dis. 14:708-719 (1992).
13. 13 R. W. Sutter and S. L. Cochi, Pertussis hospitalizations and mortality in the United States, 1985-1988: evaluation of the completeness of national reporting, JAMA 267:386-391 (1992).
14. 14 Centers for Disease Control and Prevention, Pertussis: United States, January 1992-June 1995, Morb. Mortal. Wkly. Rep. 44:526-529 (1995).
15. 15 Centers for Disease Control and Prevention, Table III, Morb. Mortal. Wkly Rep. 45:1141 (1996).
16. 16 Centers for Disease Control and Prevention, Resurgence of pertussis: United States, 1993, Morb. Mortal. Wkly Rep. 42:952-960 (1993).
17. 17 P. E. M. Fine and J. A. Clarkson, Distribution of immunity to pertussis in the population of England and Wales, J. Hyg. (Camb.) 92:21-36 (1984).
18. 18 P. E. M. Fine and J. A. Clarkson, Reflections on the efficacy of pertussis vaccines, Rev. Infect. Dis. 9:866-883 (1987).
19. 19 E. G. Knox and H. S. Shannon, A model basis for the control of whooping cough, Int. J. Epidemiol. 15:544-552 (1986).
20. 20 B. T. Grenfell and R. M. Anderson, Pertussis in England and Wales: an investigation of transmission dynamics and control by mass vaccination, Proc. R. Soc. Lond. B 236:213-252 (1989).
21. 21 F. Hoppensteadt, Mathematical Theories of Populations: Demographics, Genetics and Epidemics, SIAM, Philadelphia, PA, 1975.
22. 22 K. Dietz, Transmission and control of arboviral diseases. In Epidemiology, SIMS Utah Conference Proceedings, D. Ludwig and K. L. Cooke, Eds. SIAM, Philadelphia, PA, 1975, pp. 104-149.
23. 23 H. W. Hethcote, Measles and rubella in the United States, Am. J. Epidemiol. 117:2-13 (1983).
24. 24 H. W. Hethcote, Optimal ages of vaccination for measles, Math. Biosci. 89:29-52 (1988).
25. 25 R. W. Anderson and R. M. May, Vaccination and herd immunity to infectious disease, Nature 318:323-329 (1985).
26. 26 R. M. Anderson and R. M. May, Infectious Diseases of Humans: Dynamics and Control, Oxford University Press, Oxford, UK, 1991.
27. 27 R. M. Anderson and R. M. May, Age-related changes in the rate of disease transmission: implications for the design of vaccination programmes, J. Hyg. (Camb.) 94:365-436 (1985).
28. 28 H. R. Babad, D. J. Nokes, N. J. Gay, E. Miller, P. Morgan-Capner, and R. M. Anderson, Predicting the impact of measles vaccination in England and Wales: model validation and analysis of policy options, Epidemiol. Infect. 114:319-344 (1995).
29. 29 V. Rouderfer, H. W. Hethcote, and N. G. Becker, Waning immunity and its effects of vaccination schedules, Math. Biosci. 124:59-82 (1993).
30. 30 K. Dietz, The evaluation of rubella vaccination strategies. In The Mathematical Theory of the Dynamics of Biological Populations, Vol. 2, R. W. Hiorns and D. Cooke, Eds., Academic Press, London, 1981, pp. 81-98.
31. 31 M. E. Halloran, C. J. Struchiner, and L. Watelet, Epidemiologic effects of vaccines with complex direct effects in an age-structured population, Math Biosci. 121:193-225 (1994).
32. 32 D. Greenhalgh and K. Dietz, The effect of different mixing patterns on vaccination programs. In Models for Infectious Human Diseases, V. Isham and G. F. J. Medley, Eds., Cambridge University Press, Cambridge, UK, 1996, pp. 86-89.
33. 33 W. J. Edmunds, G. F. Medley, and D. J. Nokes, The design of immunization programmes against hepatitus B virus in developing countries. In Models for Infectious Human Diseases, V. Isham and G. F. H. Medley, Eds., Cambridge University Press, Cambridge, UK, 1996, pp. 83-85.
34. 34 A. R. McLean and S. M. Blower, Imperfect vaccines and herd immunity to HIV, Proc. R. Soc. Lond. B 253:9-13 (1993).
35. 35 U.S. Bureau of the Census, Statistical Abstract of the United States, 1994, Government Printing Office, Washington, DC, 1994.
36. 36 N. Halsey and A. Galazka, The efficacy of DPT and oral poliomyelitis immunization schedules initiated from birth to 12 weeks of age, Bull. WHO 63:1151-1169 (1985).
37. 37 Report of the Committee on Infectious Diseases, 18th ed. (Redbook), American Academy of Pediatrics, Evanston, IL, 1977.
38. 38 H. W. Hethcote, H. W. Stech, and P. van den Driessche, Periodicity and stability in epidemic models: a survey. In Differential Equations and Applications in Ecology, Epidemics and Population Problems, S. N. Busenberg and K. L. Cooke, Eds., Academic Press, New York, 1981, pp. 65-82.
39. 39 H. W. Hethcote, An immunization model for a heterogeneous population, Theor. Popul. Biol. 14:338-349 (1978).
40. 40 J. Mena-Lorca and H. W. Hethcote, Dynamic models of infectious diseases as regulators of population sizes, J. Math. Biol. 30:693-716 (1992).
41. 41 M. C. M. DeJong, O. Diekman, and J. A. P. Heesterbeek, How does transmission depend on population size? In Epidemic Models: Their Structure and Relation to Data. D. Mollison, Ed., Cambridge University Press, Cambridge, UK, 1995, pp. 84-94.
42. 42 K. M. Edwards, M. D. Decker, B. S. Graham, J. Mezzatesta, J. Scott, and J. Hackell, Adult immunization with acellular pertussis vaccine, JAMA 269:53-56 (1993).
43. 43 J. D. Cherry, Acellular pertussis vaccines: a solution to the pertussis problem, J. Infect. Dis. 168:21-24 (1993).
44. 44 M. D. Greco, S. Salmaso, P. Mastrantonio, M. Giuliano, A. E. Tozzi, A. Anemona, M. L. Ciofi Degli Atti, A. Giammanco, P. Panei, W. C. Blackwelder, D. L. Klein, S. G. F. Wassilak, and the Progetto Pertosse Working Group, A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis, N. England. J. Med. 334:341-348 (1996).
45. 45 B. T. Grenfell and R. M. Anderson, The estimation of age related rates of infection from case notifications and serological data, J. Hyg. 95:419-436 (1985).
46. 46 S. D. Collins, Age incidence of the common communicable diseases of children, Publ. Health Rep. 44:763-826 (1929).
47. 47 H. W. Hethcote, J. A. Yorke, and A. Nold, Gonorrhea modeling: comparison of control methods, Math. Biosci. 58:93-109 (1982).
48. 48 H. W. Hethcote and J. A. Yorke, Gonorrhea Transmission Dynamics and Control. Lecture Notes in Biomathematics 56, Springer-Verlag, New York, 1984.
49. 49 H. W. Hethcote and J. W. Van Ark, Epidemiological models for heterogeneous populations: proportionate mixing, parameter estimation, and immunization programs, Math. Biosci. 84:85-118 (1987).
50. 50 H. W. Hethcote, Modeling heterogeneous mixing in infectious disease dynamics. In Models for Infectious Human Diseases, V. Isham and G. F. H. Medley, Eds., Cambridge University Press, Cambridge, UK, 1996, pp. 215-238.
51. 51 H. W. Hethcote, J. W. Van Ark, and I. M. Longini, Jr., A simulation model of AIDS in San Francisco I: model formulation and parameter estimation, Math. Biosci. 106:203-222 (1991).
52. 52 H. W. Hethcote, J. W. Van Ark, and J. M. Karon, A simulation model of AIDS in San Francisco II: simulations, therapy, and sensitivity analysis, Math. Biosci. 106:223-247 (1991).
53. 53 H. W. Hethcote and J. W. Van Ark, Modeling HIV Transmission and AIDS in the United States. Lecture Notes in Biomathematics 95, Springer-Verlag, New York, 1992.
54. 54 S. P. Blythe and C. Castillo-Chavez, Like with like preference and sexual mixing models, Math. Biosci. 96:221-238 (1989).
55. 55 I. G. Marschner, The effect of preferential mixing on the growth of an epidemic, Math. Biosci. 109:39-67 (1992).
56. 56 S. J. Schwager, C. Castillo-Chavez, and H. W. Hethcote, Statistical and mathematical approaches in HIV/AIDS modeling: a review. In Mathematical and Statistical Approaches to AIDS Epidemiology, C. C. Castillo-Chavez, Ed., Lecture Notes in Biomathematics 83, Springer-Verlag, New York, 1989, pp. 2-35.
57. 57 A. Nold, Heterogeneity in disease transmission modeling, Math Biosci. 52:227-240 (1980).
58. 58 J. A. Jacquez, C. P. Simon, J. Koopman, L. Sattenspiel, and T. Perry, Modeling and the analysis of HIV transmission: the effect of contact patterns, Math. Biosci. 92:119-199 (1988).
59. 59 D. Jenkinson, Duration of effectiveness of pertussis vaccine: evidence from a 10-year community study, Br. Med. J. 296:612-614 (1988).
60. 60 H. J. Lambert, Epidemiology of a small pertussis outbreak in Kent county, Michigan, Publ. Health Rep. 80:365-369 (1965).
61. 61 Q. He, M. K. Viljanen, S. Nikkari, R. Lytikainen, and J. Mertsola, Outcomes of Bordetella pertussis infection in different age groups of an immunized population, J. Infect. Dis. 170:873-877 (1994).
62. 62 Centers for Disease Control and Prevention, Pertussis outbreaks: Massachusetts and Maryland, 1992, Morb. Mortal. Wkly. Rep. 42:197-200 (1993).
63. 63 I. Onorato, S. G. Wassilak, and B. Meade, Efficacy of whole-cell pertussis vaccine in preschool children in the United States, JAMA 267:2745-2749 (1992).
64. 64 S. R. Palmer, Vaccine efficacy and control measures in pertussis, Arch. Dis. Child. 66:854-857 (1991).
65. 65 M. E. B. Ramsey, C. P. Farrington, and E. Miller, Age-specific efficacy of pertussis vaccine during epidemic and non-epidemic periods, Epidemiol. Infect. 111:41-48 (1993).
66. 66 C. V. Broome et al., Epidemiology of pertussis, Atlanta, 1977, J. Pediatr. 98:362-367 (1981).
67. 67 Centers for Disease Control and Prevention, Vaccination coverage of 2-year-old children: United States, 1993, Morb. Moral. Wkly. Rep. 43:705-709 (1994).
68. 68 Centers for Disease Control and Prevention, Vaccination coverage among children aged 19-35 months: United States, April-June 1994, Morb. Mortal. Wkly. Rep. 44:396-398 (1995).
69. 69 Centers for Disease Control and Prevention, Vaccination coverage among children aged 19-35 months: United States, April 1994-March 1995, Morb. Mortal. Wkly. Rep. 45:145-150 (1996).
70. 70 S. M. Blower and H. Dowlatabadi, Sensitivity and uncertainty analysis of complex models of disease transmission: an HIV model, as an example, Int. Stat. Rev. 62:229-243 (1994).
71. 71 U.S. Bureau of the Census, Historical Statistics of the United States: Colonial times to 1970. Bicentennial Edition, Part 1, Government Printing Office, Washington, DC, 1975.
72. 72 M. E. Nennig, H. R. Shinefield, K. M. Edwards, S. B. Black and B. H. Fireman, Prevalence and incidence of adult pertussis in an urban population, JAMA 275:1672-1674 (1996).
73. 73 J. L. Deen, C. A. M. Mink, J. D. Cherry, P. D. Christenson, E. F. Pineda, K. Lewis, D. A. Blumberg and L. A. Ross, Household contact study of Bordetella pertussis infections, Clin. Infect. Dis. 21:1211-1219 (1995).
74. 74 J. G. Deville, J. D. Cherry, P. D. Christenson, E. Pineda, C. T. Leach, T. L. Kuhls, and S. Viker, Frequency of unrecognized Bordetella pertussis infections in adults, Clin. Infect. Dis. 21:639-642 (1995).
75. 75 L. A. Herwaldt, Pertussis in adults: what physicians need to know, Arch. Intern. Med. 109:1510-1512 (1991).
76. 76 S. W. Wright, K. M. Edwards, M. D. Decker, and M. H. Zeldin, Pertussis infection in adults with persistent cough, JAMA 273:1044-1046 (1995).
77. 77 A. J. Lotka, The stability of the normal age distribution, Proc. Natl. Acad. Sci. 8:339-345 (1922).
78. 78 A. G. McKendrick, Applications of mathematics to medical problems, Proc. Edinburgh Math. Soc. 44:98-130 (1926).